• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立预测模型并揭示免疫因素对肺癌脑转移预后的影响。

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas.

作者信息

Wang Bowen, Peng Mengjia, Li Yan, Gao Jinhang, Chang Tao

机构信息

Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.

Department of Emergency, General Hospital of Tibet Military Command, Lhasa, China.

出版信息

Front Oncol. 2025 Mar 3;15:1554242. doi: 10.3389/fonc.2025.1554242. eCollection 2025.

DOI:10.3389/fonc.2025.1554242
PMID:40098698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11911169/
Abstract

OBJECTIVE

Primary lung carcinomas (LCs) often metastasize to the brain, resulting in a grim prognosis for affected individuals. This population-based study aimed to investigate their survival period and immune status, while also establishing a predictive model.

METHODS

The records of 86,763 primary LCs from the Surveillance, Epidemiology, and End Results (SEER) database were extracted, including 15,180 cases with brain metastasis (BM) and 71,583 without BM. Univariate and multivariate Cox regression were employed to construct a prediction model. Multiple machine learning methods were applied to validate the model. Flow cytometry and ELISA were used to explore the immune status in a real-world cohort.

RESULTS

The research findings revealed a 17.49% prevalence of BM from LCs, with a median survival of 8 months, compared with 16 months for their counterparts (0.001). A nomogram was developed to predict survival at 1, 3, and 5 years on the basis of these variables, with the time-dependent area under the curve (AUC) of 0.857, 0.814, and 0.786, respectively. Moreover, several machine learning approaches have further verified the reliability of this model's performance. Flow cytometry and ELISA analysis suggested the prediction model was related the immune status.

CONCLUSIONS

BM from LCs have an inferior prognosis. Considering the substantial impact of these factors, the nomogram model is a valuable tool for guiding clinical decision-making in managing patients with this condition.

摘要

目的

原发性肺癌(LCs)常转移至脑,导致受影响个体预后不佳。这项基于人群的研究旨在调查其生存期和免疫状态,同时建立一个预测模型。

方法

从监测、流行病学和最终结果(SEER)数据库中提取86763例原发性LCs的记录,其中包括15180例有脑转移(BM)的病例和71583例无BM的病例。采用单因素和多因素Cox回归构建预测模型。应用多种机器学习方法对模型进行验证。采用流式细胞术和酶联免疫吸附测定(ELISA)在真实队列中探索免疫状态。

结果

研究结果显示,LCs发生BM的患病率为17.49%,中位生存期为8个月,而无BM的患者为16个月(P<0.001)。基于这些变量开发了一个列线图,以预测1年、3年和5年的生存率,其时间依赖性曲线下面积(AUC)分别为0.857、0.814和0.786。此外,几种机器学习方法进一步验证了该模型性能的可靠性。流式细胞术和ELISA分析表明,预测模型与免疫状态相关。

结论

LCs发生BM的预后较差。考虑到这些因素的重大影响,列线图模型是指导此类患者临床决策的有价值工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/9bef4b8cbf9c/fonc-15-1554242-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/5eeff52bd9ae/fonc-15-1554242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/b530bcdf059d/fonc-15-1554242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/68069219c615/fonc-15-1554242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/59c1ee4081af/fonc-15-1554242-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/9bef4b8cbf9c/fonc-15-1554242-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/5eeff52bd9ae/fonc-15-1554242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/b530bcdf059d/fonc-15-1554242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/68069219c615/fonc-15-1554242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/59c1ee4081af/fonc-15-1554242-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c4/11911169/9bef4b8cbf9c/fonc-15-1554242-g005.jpg

相似文献

1
Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas.建立预测模型并揭示免疫因素对肺癌脑转移预后的影响。
Front Oncol. 2025 Mar 3;15:1554242. doi: 10.3389/fonc.2025.1554242. eCollection 2025.
2
Developing a nomogram model and prognostic analysis of nasopharyngeal squamous cell carcinoma patients: a population-based study.基于人群的研究:开发鼻咽癌患者列线图模型和预后分析。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12165-12175. doi: 10.1007/s00432-023-05120-3. Epub 2023 Jul 10.
3
Survival analysis and prediction of early-onset colorectal cancer patients post-chemotherapy: an analysis based on the SEER database.早发性结直肠癌患者化疗后的生存分析与预测:基于监测、流行病学与最终结果(SEER)数据库的分析
Int J Colorectal Dis. 2025 Mar 22;40(1):74. doi: 10.1007/s00384-025-04853-6.
4
Establishment of a nomogram for potential prediction of lung metastasis in patients with primary limb bone tumors: a study based on the SEER database.原发性肢体骨肿瘤患者肺转移潜在预测列线图的建立:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Transl Cancer Res. 2024 Sep 30;13(9):4763-4774. doi: 10.21037/tcr-24-570. Epub 2024 Sep 21.
5
Two novel clinical tools to predict the risk of bone metastasis and overall survival in esophageal cancer patients: a large population-based retrospective cohort study.两种新型临床工具预测食管癌患者发生骨转移和总生存期的风险:一项基于大样本的回顾性队列研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11759-11777. doi: 10.1007/s00432-023-05066-6. Epub 2023 Jul 5.
6
Individualized Prediction of Overall Survival Time for Patients with Primary Intramedullary Spinal Cord Astrocytoma: A Population-Based Study.原发性脊髓髓内星形细胞瘤患者总生存时间的个体化预测:一项基于人群的研究
World Neurosurg. 2025 Jan;193:1106-1116. doi: 10.1016/j.wneu.2024.10.092. Epub 2024 Nov 21.
7
Development and validation of a prognostic nomogram for bone metastasis from lung cancer: A large population-based study.肺癌骨转移预后列线图的开发与验证:一项基于大人群的研究。
Front Oncol. 2022 Sep 30;12:1005668. doi: 10.3389/fonc.2022.1005668. eCollection 2022.
8
A novel nomogram predicting cancer-specific survival in small cell lung cancer patients with brain metastasis.一种预测小细胞肺癌脑转移患者癌症特异性生存的新型列线图。
Transl Cancer Res. 2022 Dec;11(12):4289-4302. doi: 10.21037/tcr-22-1561.
9
Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?原发肿瘤切除术对肺癌骨转移患者生存获益的分析及总体生存个体化预测:值得吗?
Asian J Surg. 2024 Jan;47(1):333-349. doi: 10.1016/j.asjsur.2023.08.198. Epub 2023 Sep 21.
10
Nomogram for predicting the risk and prognosis of lung metastasis of four subtypes of breast cancer: A population-based study from SEER.预测四种亚型乳腺癌肺转移风险和预后的列线图:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Cancer Pathog Ther. 2024 Aug 3;3(2):154-162. doi: 10.1016/j.cpt.2024.08.001. eCollection 2025 Mar.

本文引用的文献

1
Cancer statistics, 2025.2025年癌症统计数据。
CA Cancer J Clin. 2025 Jan-Feb;75(1):10-45. doi: 10.3322/caac.21871. Epub 2025 Jan 16.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy.
脑转移和肺癌:分子生物学、自然史、免疫治疗反应和疗效的预测。
Front Immunol. 2024 Jan 12;14:1297988. doi: 10.3389/fimmu.2023.1297988. eCollection 2023.
4
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases.计算标记物用于预测非小细胞肺癌脑转移患者的个体化预后。
Clin Exp Metastasis. 2024 Feb;41(1):55-68. doi: 10.1007/s10585-023-10245-3. Epub 2023 Dec 20.
5
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges.EGFR 突变型早期 NSCLC 的围手术期治疗策略:当前证据与未来挑战。
J Thorac Oncol. 2024 Feb;19(2):199-215. doi: 10.1016/j.jtho.2023.09.1451. Epub 2023 Sep 30.
6
Gender disparities in lung cancer incidence in the United States during 2001-2019.2001-2019 年美国肺癌发病率中的性别差异。
Sci Rep. 2023 Aug 3;13(1):12581. doi: 10.1038/s41598-023-39440-8.
7
Risk factors and a new nomogram for predicting brain metastasis from lung cancer: a retrospective study.预测肺癌脑转移的危险因素及新的列线图:一项回顾性研究
Front Oncol. 2023 Jun 19;13:1092721. doi: 10.3389/fonc.2023.1092721. eCollection 2023.
8
Sex Differences in Lung Cancer.肺癌中的性别差异
Cancers (Basel). 2023 Jun 8;15(12):3111. doi: 10.3390/cancers15123111.
9
Occurrence and prognosis of lung cancer metastasis to major organs: a population-based study.肺癌转移至主要器官的发生和预后:一项基于人群的研究。
Eur J Cancer Prev. 2023 May 1;32(3):246-253. doi: 10.1097/CEJ.0000000000000785. Epub 2023 Feb 27.
10
Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis.非小细胞肺癌脑转移临床实践中的微环境与免疫治疗进展
Front Oncol. 2023 Jan 24;12:1006284. doi: 10.3389/fonc.2022.1006284. eCollection 2022.